NCT05083130

Brief Summary

The purpose of this study is comparing vital signs between standard care and prone position groups. Standard care will consist of routine clinical care, including any advice to lie in prone position as routinely recommended by participating sites. For those randomized to prone position, a special intervention team will visit patients' rooms aiming for patients to maintain the prone position for at least 8 hours a day.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P25-P50 for not_applicable covid19

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 19, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

March 8, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

June 7, 2023

Status Verified

June 1, 2023

Enrollment Period

1.1 years

First QC Date

October 10, 2021

Last Update Submit

June 5, 2023

Conditions

Keywords

prone positionsevere COVID-19acute respiratory distress syndrome (ARDS)Vietnam

Outcome Measures

Primary Outcomes (1)

  • Percentage of participants who require escalation of respiratory therapy

    Escalation of respiratory therapy within 28 days of randomization, defined as any of the following: * Escalation to next level respiratory support (with lowest level nasal cannula or face mask, escalating through HFNC to NIV or mechanical ventilation). * Intubation

    Up to 28 days after enrollment

Secondary Outcomes (4)

  • Fatal event

    Up to 28 days after enrollment

  • Duration of hospital stay

    Up to 2 months after enrollment

  • Improvement in oxygen related parameters

    Up to 28 days after enrollment

  • Number of adverse events

    Up to 28 days after enrollment

Study Arms (2)

standard care

NO INTERVENTION

Standard care will consist of routine clinical care, including any advice to lie in prone position as routinely recommended by participating sites

prone position

EXPERIMENTAL

prone position group will have a special intervention team who visits patients' rooms aiming for patients to maintain the prone position for at least 8 hours a day

Behavioral: a wake prone positioning

Interventions

The team will give written and verbal advice and if necessary aid patients' positioning themselves in the prone position for at least 8 hours per day. The exact duration of prone sessions will be determined according to ward schedules to take account of nursing procedures, meal times and mitigation strategies. Other methods to encourage the maintenance of prone position includes phone calls to patients, carers or education of carers.

prone position

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Probable or confirmed COVID-19 infection according to WHO criteria
  • Moderate or severe COVID-19 respiratory infection according to Vietnamese guidelines
  • Requirement for supplemental oxygen therapy

You may not qualify if:

  • Invasive mechanical ventilation, or non-invasive ventilation (NIV) with CPAP or BiPAP or imminent need for these
  • Contraindications to prone position (see Appendix 5)
  • Pregnancy
  • Severe obesity (BMI \>35),
  • Altered level of consciousness (GCS \<13)
  • Attending doctor judged prone position to be unsuitable for the patient for any reason
  • Patients in whom there is a decision that care will not be escalated
  • Failure to have informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Tropical Diseases

Ho Chi Minh City, Vietnam

Location

Related Publications (4)

  • Dondorp AM, Hayat M, Aryal D, Beane A, Schultz MJ. Respiratory Support in COVID-19 Patients, with a Focus on Resource-Limited Settings. Am J Trop Med Hyg. 2020 Jun;102(6):1191-1197. doi: 10.4269/ajtmh.20-0283.

    PMID: 32319424BACKGROUND
  • Gonzalez-Seguel F, Pinto-Concha JJ, Aranis N, Leppe J. Adverse Events of Prone Positioning in Mechanically Ventilated Adults With ARDS. Respir Care. 2021 Dec;66(12):1898-1911. doi: 10.4187/respcare.09194. Epub 2021 Jul 23.

    PMID: 34301802BACKGROUND
  • Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E; Awake Prone Positioning Meta-Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.

    PMID: 34425070BACKGROUND
  • Phong NT, Duc DH, Hai HB, Nguyen NT, Khoa LDV, Khanh LTT, Tran LHB, Linh NTM, Van CTC, Thao DP, Trinh NTD, Kieu PT, Truong NT, Hoang VT, Ngoc NT, Vien TTD, Ly VT, Khoa TD, Beane A, Anibal J; OUCRU COVID RESEACH GROUP; Thwaites GE, Geskus R, Clifton D, Dung NTP, Kestelyn E, Glover G, Tan LV, Yen LM, Tung NLN, Dung NT, Thwaites CL. Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial. Wellcome Open Res. 2024 Dec 7;9:543. doi: 10.12688/wellcomeopenres.22792.2. eCollection 2024.

Related Links

MeSH Terms

Conditions

COVID-19Respiratory InsufficiencyRespiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Louise C Thwaites, MD. PhD.

    University of Oxford, UK

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Open label randomised controlled trial comparing standard care to prone position
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2021

First Posted

October 19, 2021

Study Start

March 8, 2022

Primary Completion

March 31, 2023

Study Completion

May 1, 2023

Last Updated

June 7, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will share

Anonymised data of this study may be requested for publication by journals. Sharing anonymised data with future similar/suitable studies will be decided by the sponsor, PIs and the authority agency where the data was collected. No identifiable information will be shared with any other person/organisation

Shared Documents
STUDY PROTOCOL

Locations